Summary
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.
According to APO Research, The global Enoxaparin Sodium market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Enoxaparin Sodium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Enoxaparin Sodium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Enoxaparin Sodium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Enoxaparin Sodium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Enoxaparin Sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Enoxaparin Sodium, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Enoxaparin Sodium, also provides the sales of main regions and countries. Of the upcoming market potential for Enoxaparin Sodium, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Enoxaparin Sodium sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Enoxaparin Sodium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Enoxaparin Sodium sales, projected growth trends, production technology, application and end-user industry.
Enoxaparin Sodium segment by Company
Sanofi
Teva
Techdow (Hepalink)
Fresenius Kabi
Rovi
Amphastar
Nanjing King-friend
Sandoz
Apotex
Hangzhou Jiuyuan Gene Engineering
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Suzhou Erye Pharmaceutical
Changzhou Qianhong Bio-pharma
Hebei Changshan Biochemical Pharmaceutical
Beijing SL Pharmaceutical
Huadong Medicine
Bharat Serums
INTAS
LUPIN
Troikaa Pharmaceuticals
Aristopharma
Fosun Pharma
SciencePharma
PISA
Enoxaparin Sodium segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Enoxaparin Sodium segment by Application
Hospital
Clinic
Others
Enoxaparin Sodium segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Enoxaparin Sodium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enoxaparin Sodium sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Enoxaparin Sodium Market by Type
1.2.1 Global Enoxaparin Sodium Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Enoxaparin Sodium Market by Application
1.3.1 Global Enoxaparin Sodium Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Enoxaparin Sodium Market Dynamics
2.1 Enoxaparin Sodium Industry Trends
2.2 Enoxaparin Sodium Industry Drivers
2.3 Enoxaparin Sodium Industry Opportunities and Challenges
2.4 Enoxaparin Sodium Industry Restraints
3 Global Market Growth Prospects
3.1 Global Enoxaparin Sodium Revenue Estimates and Forecasts (2019-2030)
3.2 Global Enoxaparin Sodium Revenue by Region
3.2.1 Global Enoxaparin Sodium Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Enoxaparin Sodium Revenue by Region (2019-2024)
3.2.3 Global Enoxaparin Sodium Revenue by Region (2025-2030)
3.2.4 Global Enoxaparin Sodium Revenue Market Share by Region (2019-2030)
3.3 Global Enoxaparin Sodium Sales Estimates and Forecasts 2019-2030
3.4 Global Enoxaparin Sodium Sales by Region
3.4.1 Global Enoxaparin Sodium Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Enoxaparin Sodium Sales by Region (2019-2024)
3.4.3 Global Enoxaparin Sodium Sales by Region (2025-2030)
3.4.4 Global Enoxaparin Sodium Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Enoxaparin Sodium Revenue by Manufacturers
4.1.1 Global Enoxaparin Sodium Revenue by Manufacturers (2019-2024)
4.1.2 Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Enoxaparin Sodium Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Enoxaparin Sodium Sales by Manufacturers
4.2.1 Global Enoxaparin Sodium Sales by Manufacturers (2019-2024)
4.2.2 Global Enoxaparin Sodium Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Enoxaparin Sodium Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Enoxaparin Sodium Sales Price by Manufacturers (2019-2024)
4.4 Global Enoxaparin Sodium Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Enoxaparin Sodium Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Enoxaparin Sodium Manufacturers, Product Type & Application
4.7 Global Enoxaparin Sodium Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Enoxaparin Sodium Market CR5 and HHI
4.8.2 2023 Enoxaparin Sodium Tier 1, Tier 2, and Tier 3
5 Enoxaparin Sodium Market by Type
5.1 Global Enoxaparin Sodium Revenue by Type
5.1.1 Global Enoxaparin Sodium Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Enoxaparin Sodium Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Enoxaparin Sodium Revenue Market Share by Type (2019-2030)
5.2 Global Enoxaparin Sodium Sales by Type
5.2.1 Global Enoxaparin Sodium Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Enoxaparin Sodium Sales by Type (2019-2030) & (M Units)
5.2.3 Global Enoxaparin Sodium Sales Market Share by Type (2019-2030)
5.3 Global Enoxaparin Sodium Price by Type
6 Enoxaparin Sodium Market by Application
6.1 Global Enoxaparin Sodium Revenue by Application
6.1.1 Global Enoxaparin Sodium Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Enoxaparin Sodium Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Enoxaparin Sodium Revenue Market Share by Application (2019-2030)
6.2 Global Enoxaparin Sodium Sales by Application
6.2.1 Global Enoxaparin Sodium Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Enoxaparin Sodium Sales by Application (2019-2030) & (M Units)
6.2.3 Global Enoxaparin Sodium Sales Market Share by Application (2019-2030)
6.3 Global Enoxaparin Sodium Price by Application
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Comapny Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Enoxaparin Sodium Product Portfolio
7.1.5 Sanofi Recent Developments
7.2 Teva
7.2.1 Teva Comapny Information
7.2.2 Teva Business Overview
7.2.3 Teva Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Teva Enoxaparin Sodium Product Portfolio
7.2.5 Teva Recent Developments
7.3 Techdow (Hepalink)
7.3.1 Techdow (Hepalink) Comapny Information
7.3.2 Techdow (Hepalink) Business Overview
7.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
7.3.5 Techdow (Hepalink) Recent Developments
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Comapny Information
7.4.2 Fresenius Kabi Business Overview
7.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
7.4.5 Fresenius Kabi Recent Developments
7.5 Rovi
7.5.1 Rovi Comapny Information
7.5.2 Rovi Business Overview
7.5.3 Rovi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Rovi Enoxaparin Sodium Product Portfolio
7.5.5 Rovi Recent Developments
7.6 Amphastar
7.6.1 Amphastar Comapny Information
7.6.2 Amphastar Business Overview
7.6.3 Amphastar Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Amphastar Enoxaparin Sodium Product Portfolio
7.6.5 Amphastar Recent Developments
7.7 Nanjing King-friend
7.7.1 Nanjing King-friend Comapny Information
7.7.2 Nanjing King-friend Business Overview
7.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
7.7.5 Nanjing King-friend Recent Developments
7.8 Sandoz
7.8.1 Sandoz Comapny Information
7.8.2 Sandoz Business Overview
7.8.3 Sandoz Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Sandoz Enoxaparin Sodium Product Portfolio
7.8.5 Sandoz Recent Developments
7.9 Apotex
7.9.1 Apotex Comapny Information
7.9.2 Apotex Business Overview
7.9.3 Apotex Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Apotex Enoxaparin Sodium Product Portfolio
7.9.5 Apotex Recent Developments
7.10 Hangzhou Jiuyuan Gene Engineering
7.10.1 Hangzhou Jiuyuan Gene Engineering Comapny Information
7.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
7.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
7.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
7.11 Cipla
7.11.1 Cipla Comapny Information
7.11.2 Cipla Business Overview
7.11.3 Cipla Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Cipla Enoxaparin Sodium Product Portfolio
7.11.5 Cipla Recent Developments
7.12 Taj Pharma
7.12.1 Taj Pharma Comapny Information
7.12.2 Taj Pharma Business Overview
7.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
7.12.5 Taj Pharma Recent Developments
7.13 Chengdu Baiyu Pharmaceutical
7.13.1 Chengdu Baiyu Pharmaceutical Comapny Information
7.13.2 Chengdu Baiyu Pharmaceutical Business Overview
7.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
7.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
7.14 Suzhou Erye Pharmaceutical
7.14.1 Suzhou Erye Pharmaceutical Comapny Information
7.14.2 Suzhou Erye Pharmaceutical Business Overview
7.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
7.14.5 Suzhou Erye Pharmaceutical Recent Developments
7.15 Changzhou Qianhong Bio-pharma
7.15.1 Changzhou Qianhong Bio-pharma Comapny Information
7.15.2 Changzhou Qianhong Bio-pharma Business Overview
7.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
7.15.5 Changzhou Qianhong Bio-pharma Recent Developments
7.16 Hebei Changshan Biochemical Pharmaceutical
7.16.1 Hebei Changshan Biochemical Pharmaceutical Comapny Information
7.16.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
7.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
7.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
7.17 Beijing SL Pharmaceutical
7.17.1 Beijing SL Pharmaceutical Comapny Information
7.17.2 Beijing SL Pharmaceutical Business Overview
7.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
7.17.5 Beijing SL Pharmaceutical Recent Developments
7.18 Huadong Medicine
7.18.1 Huadong Medicine Comapny Information
7.18.2 Huadong Medicine Business Overview
7.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
7.18.5 Huadong Medicine Recent Developments
7.19 Bharat Serums
7.19.1 Bharat Serums Comapny Information
7.19.2 Bharat Serums Business Overview
7.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
7.19.5 Bharat Serums Recent Developments
7.20 INTAS
7.20.1 INTAS Comapny Information
7.20.2 INTAS Business Overview
7.20.3 INTAS Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.20.4 INTAS Enoxaparin Sodium Product Portfolio
7.20.5 INTAS Recent Developments
7.21 LUPIN
7.21.1 LUPIN Comapny Information
7.21.2 LUPIN Business Overview
7.21.3 LUPIN Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.21.4 LUPIN Enoxaparin Sodium Product Portfolio
7.21.5 LUPIN Recent Developments
7.22 Troikaa Pharmaceuticals
7.22.1 Troikaa Pharmaceuticals Comapny Information
7.22.2 Troikaa Pharmaceuticals Business Overview
7.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
7.22.5 Troikaa Pharmaceuticals Recent Developments
7.23 Aristopharma
7.23.1 Aristopharma Comapny Information
7.23.2 Aristopharma Business Overview
7.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
7.23.5 Aristopharma Recent Developments
7.24 Fosun Pharma
7.24.1 Fosun Pharma Comapny Information
7.24.2 Fosun Pharma Business Overview
7.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
7.24.5 Fosun Pharma Recent Developments
7.25 SciencePharma
7.25.1 SciencePharma Comapny Information
7.25.2 SciencePharma Business Overview
7.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
7.25.5 SciencePharma Recent Developments
7.26 PISA
7.26.1 PISA Comapny Information
7.26.2 PISA Business Overview
7.26.3 PISA Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2019-2024)
7.26.4 PISA Enoxaparin Sodium Product Portfolio
7.26.5 PISA Recent Developments
8 North America
8.1 North America Enoxaparin Sodium Market Size by Type
8.1.1 North America Enoxaparin Sodium Revenue by Type (2019-2030)
8.1.2 North America Enoxaparin Sodium Sales by Type (2019-2030)
8.1.3 North America Enoxaparin Sodium Price by Type (2019-2030)
8.2 North America Enoxaparin Sodium Market Size by Application
8.2.1 North America Enoxaparin Sodium Revenue by Application (2019-2030)
8.2.2 North America Enoxaparin Sodium Sales by Application (2019-2030)
8.2.3 North America Enoxaparin Sodium Price by Application (2019-2030)
8.3 North America Enoxaparin Sodium Market Size by Country
8.3.1 North America Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Enoxaparin Sodium Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Enoxaparin Sodium Market Size by Type
9.1.1 Europe Enoxaparin Sodium Revenue by Type (2019-2030)
9.1.2 Europe Enoxaparin Sodium Sales by Type (2019-2030)
9.1.3 Europe Enoxaparin Sodium Price by Type (2019-2030)
9.2 Europe Enoxaparin Sodium Market Size by Application
9.2.1 Europe Enoxaparin Sodium Revenue by Application (2019-2030)
9.2.2 Europe Enoxaparin Sodium Sales by Application (2019-2030)
9.2.3 Europe Enoxaparin Sodium Price by Application (2019-2030)
9.3 Europe Enoxaparin Sodium Market Size by Country
9.3.1 Europe Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Enoxaparin Sodium Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Enoxaparin Sodium Market Size by Type
10.1.1 China Enoxaparin Sodium Revenue by Type (2019-2030)
10.1.2 China Enoxaparin Sodium Sales by Type (2019-2030)
10.1.3 China Enoxaparin Sodium Price by Type (2019-2030)
10.2 China Enoxaparin Sodium Market Size by Application
10.2.1 China Enoxaparin Sodium Revenue by Application (2019-2030)
10.2.2 China Enoxaparin Sodium Sales by Application (2019-2030)
10.2.3 China Enoxaparin Sodium Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Enoxaparin Sodium Market Size by Type
11.1.1 Asia Enoxaparin Sodium Revenue by Type (2019-2030)
11.1.2 Asia Enoxaparin Sodium Sales by Type (2019-2030)
11.1.3 Asia Enoxaparin Sodium Price by Type (2019-2030)
11.2 Asia Enoxaparin Sodium Market Size by Application
11.2.1 Asia Enoxaparin Sodium Revenue by Application (2019-2030)
11.2.2 Asia Enoxaparin Sodium Sales by Application (2019-2030)
11.2.3 Asia Enoxaparin Sodium Price by Application (2019-2030)
11.3 Asia Enoxaparin Sodium Market Size by Country
11.3.1 Asia Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Enoxaparin Sodium Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Enoxaparin Sodium Market Size by Type
12.1.1 MEALA Enoxaparin Sodium Revenue by Type (2019-2030)
12.1.2 MEALA Enoxaparin Sodium Sales by Type (2019-2030)
12.1.3 MEALA Enoxaparin Sodium Price by Type (2019-2030)
12.2 MEALA Enoxaparin Sodium Market Size by Application
12.2.1 MEALA Enoxaparin Sodium Revenue by Application (2019-2030)
12.2.2 MEALA Enoxaparin Sodium Sales by Application (2019-2030)
12.2.3 MEALA Enoxaparin Sodium Price by Application (2019-2030)
12.3 MEALA Enoxaparin Sodium Market Size by Country
12.3.1 MEALA Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Enoxaparin Sodium Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Enoxaparin Sodium Value Chain Analysis
13.1.1 Enoxaparin Sodium Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Enoxaparin Sodium Production Mode & Process
13.2 Enoxaparin Sodium Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Enoxaparin Sodium Distributors
13.2.3 Enoxaparin Sodium Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Enoxaparin Sodium Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. 20 mg/0.2mL Major Manufacturers
Table 3. 30 mg/0.3mL Major Manufacturers
Table 4. 40 mg/0.4mL Major Manufacturers
Table 5. 60 mg/0.6mL Major Manufacturers
Table 6. 80 mg/0.8mL Major Manufacturers
Table 7. 100 mg/1mL Major Manufacturers
Table 8. 120 mg/0.8mL Major Manufacturers
Table 9. 150 mg/1mL Major Manufacturers
Table 10. 300mg/3mL Major Manufacturers
Table 11. Global Enoxaparin Sodium Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 12. Hospital Major Manufacturers
Table 13. Clinic Major Manufacturers
Table 14. Others Major Manufacturers
Table 15. Enoxaparin Sodium Industry Trends
Table 16. Enoxaparin Sodium Industry Drivers
Table 17. Enoxaparin Sodium Industry Opportunities and Challenges
Table 18. Enoxaparin Sodium Industry Restraints
Table 19. Global Enoxaparin Sodium Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 20. Global Enoxaparin Sodium Revenue by Region (2019-2024) & (US$ Million)
Table 21. Global Enoxaparin Sodium Revenue by Region (2025-2030) & (US$ Million)
Table 22. Global Enoxaparin Sodium Revenue Market Share by Region (2019-2024)
Table 23. Global Enoxaparin Sodium Revenue Market Share by Region (2025-2030)
Table 24. Global Enoxaparin Sodium Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Units)
Table 25. Global Enoxaparin Sodium Sales by Region (2019-2024) & (M Units)
Table 26. Global Enoxaparin Sodium Sales by Region (2025-2030) & (M Units)
Table 27. Global Enoxaparin Sodium Sales Market Share by Region (2019-2024)
Table 28. Global Enoxaparin Sodium Sales Market Share by Region (2025-2030)
Table 29. Global Enoxaparin Sodium Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 30. Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2019-2024)
Table 31. Global Enoxaparin Sodium Sales by Manufacturers (US$ Million) & (2019-2024)
Table 32. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2019-2024)
Table 33. Global Enoxaparin Sodium Sales Price (US$/Unit) of Manufacturers (2019-2024)
Table 34. Global Enoxaparin Sodium Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 35. Global Enoxaparin Sodium Key Manufacturers Manufacturing Sites & Headquarters
Table 36. Global Enoxaparin Sodium Manufacturers, Product Type & Application
Table 37. Global Enoxaparin Sodium Manufacturers Commercialization Time
Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 39. Global Enoxaparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Enoxaparin Sodium Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Enoxaparin Sodium Revenue by Type (2019-2024) & (US$ Million)
Table 42. Global Enoxaparin Sodium Revenue by Type (2025-2030) & (US$ Million)
Table 43. Global Enoxaparin Sodium Revenue Market Share by Type (2019-2024)
Table 44. Global Enoxaparin Sodium Revenue Market Share by Type (2025-2030)
Table 45. Global Enoxaparin Sodium Sales by Type 2019 VS 2023 VS 2030 (M Units)
Table 46. Global Enoxaparin Sodium Sales by Type (2019-2024) & (M Units)
Table 47. Global Enoxaparin Sodium Sales by Type (2025-2030) & (M Units)
Table 48. Global Enoxaparin Sodium Sales Market Share by Type (2019-2024)
Table 49. Global Enoxaparin Sodium Sales Market Share by Type (2025-2030)
Table 50. Global Enoxaparin Sodium Price by Type (2019-2024) & (US$/Unit)
Table 51. Global Enoxaparin Sodium Price by Type (2025-2030) & (US$/Unit)
Table 52. Global Enoxaparin Sodium Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 53. Global Enoxaparin Sodium Revenue by Application (2019-2024) & (US$ Million)
Table 54. Global Enoxaparin Sodium Revenue by Application (2025-2030) & (US$ Million)
Table 55. Global Enoxaparin Sodium Revenue Market Share by Application (2019-2024)
Table 56. Global Enoxaparin Sodium Revenue Market Share by Application (2025-2030)
Table 57. Global Enoxaparin Sodium Sales by Application 2019 VS 2023 VS 2030 (M Units)
Table 58. Global Enoxaparin Sodium Sales by Application (2019-2024) & (M Units)
Table 59. Global Enoxaparin Sodium Sales by Application (2025-2030) & (M Units)
Table 60. Global Enoxaparin Sodium Sales Market Share by Application (2019-2024)
Table 61. Global Enoxaparin Sodium Sales Market Share by Application (2025-2030)
Table 62. Global Enoxaparin Sodium Price by Application (2019-2024) & (US$/Unit)
Table 63. Global Enoxaparin Sodium Price by Application (2025-2030) & (US$/Unit)
Table 64. Sanofi Company Information
Table 65. Sanofi Business Overview
Table 66. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 67. Sanofi Enoxaparin Sodium Product Portfolio
Table 68. Sanofi Recent Development
Table 69. Teva Company Information
Table 70. Teva Business Overview
Table 71. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 72. Teva Enoxaparin Sodium Product Portfolio
Table 73. Teva Recent Development
Table 74. Techdow (Hepalink) Company Information
Table 75. Techdow (Hepalink) Business Overview
Table 76. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
Table 78. Techdow (Hepalink) Recent Development
Table 79. Fresenius Kabi Company Information
Table 80. Fresenius Kabi Business Overview
Table 81. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Fresenius Kabi Enoxaparin Sodium Product Portfolio
Table 83. Fresenius Kabi Recent Development
Table 84. Rovi Company Information
Table 85. Rovi Business Overview
Table 86. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Rovi Enoxaparin Sodium Product Portfolio
Table 88. Rovi Recent Development
Table 89. Amphastar Company Information
Table 90. Amphastar Business Overview
Table 91. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Amphastar Enoxaparin Sodium Product Portfolio
Table 93. Amphastar Recent Development
Table 94. Nanjing King-friend Company Information
Table 95. Nanjing King-friend Business Overview
Table 96. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Nanjing King-friend Enoxaparin Sodium Product Portfolio
Table 98. Nanjing King-friend Recent Development
Table 99. Sandoz Company Information
Table 100. Sandoz Business Overview
Table 101. Sandoz Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Sandoz Enoxaparin Sodium Product Portfolio
Table 103. Sandoz Recent Development
Table 104. Apotex Company Information
Table 105. Apotex Business Overview
Table 106. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Apotex Enoxaparin Sodium Product Portfolio
Table 108. Apotex Recent Development
Table 109. Hangzhou Jiuyuan Gene Engineering Company Information
Table 110. Hangzhou Jiuyuan Gene Engineering Business Overview
Table 111. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
Table 113. Hangzhou Jiuyuan Gene Engineering Recent Development
Table 114. Cipla Company Information
Table 115. Cipla Business Overview
Table 116. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Cipla Enoxaparin Sodium Product Portfolio
Table 118. Cipla Recent Development
Table 119. Taj Pharma Company Information
Table 120. Taj Pharma Business Overview
Table 121. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Taj Pharma Enoxaparin Sodium Product Portfolio
Table 123. Taj Pharma Recent Development
Table 124. Chengdu Baiyu Pharmaceutical Company Information
Table 125. Chengdu Baiyu Pharmaceutical Business Overview
Table 126. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 128. Chengdu Baiyu Pharmaceutical Recent Development
Table 129. Suzhou Erye Pharmaceutical Company Information
Table 130. Suzhou Erye Pharmaceutical Business Overview
Table 131. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 133. Suzhou Erye Pharmaceutical Recent Development
Table 134. Changzhou Qianhong Bio-pharma Company Information
Table 135. Changzhou Qianhong Bio-pharma Business Overview
Table 136. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
Table 138. Changzhou Qianhong Bio-pharma Recent Development
Table 139. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 140. Hebei Changshan Biochemical Pharmaceutical Business Overview
Table 141. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 143. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 144. Beijing SL Pharmaceutical Company Information
Table 145. Beijing SL Pharmaceutical Business Overview
Table 146. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
Table 148. Beijing SL Pharmaceutical Recent Development
Table 149. Huadong Medicine Company Information
Table 150. Huadong Medicine Business Overview
Table 151. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Huadong Medicine Enoxaparin Sodium Product Portfolio
Table 153. Huadong Medicine Recent Development
Table 154. Bharat Serums Company Information
Table 155. Bharat Serums Business Overview
Table 156. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. Bharat Serums Enoxaparin Sodium Product Portfolio
Table 158. Bharat Serums Recent Development
Table 159. INTAS Company Information
Table 160. INTAS Business Overview
Table 161. INTAS Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. INTAS Enoxaparin Sodium Product Portfolio
Table 163. INTAS Recent Development
Table 164. LUPIN Company Information
Table 165. LUPIN Business Overview
Table 166. LUPIN Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 167. LUPIN Enoxaparin Sodium Product Portfolio
Table 168. LUPIN Recent Development
Table 169. Troikaa Pharmaceuticals Company Information
Table 170. Troikaa Pharmaceuticals Business Overview
Table 171. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 172. Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
Table 173. Troikaa Pharmaceuticals Recent Development
Table 174. Aristopharma Company Information
Table 175. Aristopharma Business Overview
Table 176. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 177. Aristopharma Enoxaparin Sodium Product Portfolio
Table 178. Aristopharma Recent Development
Table 179. Fosun Pharma Company Information
Table 180. Fosun Pharma Business Overview
Table 181. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 182. Fosun Pharma Enoxaparin Sodium Product Portfolio
Table 183. Fosun Pharma Recent Development
Table 184. SciencePharma Company Information
Table 185. SciencePharma Business Overview
Table 186. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 187. SciencePharma Enoxaparin Sodium Product Portfolio
Table 188. SciencePharma Recent Development
Table 189. PISA Company Information
Table 190. PISA Business Overview
Table 191. PISA Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 192. PISA Enoxaparin Sodium Product Portfolio
Table 193. PISA Recent Development
Table 194. North America Enoxaparin Sodium Revenue by Type (2019-2024) & (US$ Million)
Table 195. North America Enoxaparin Sodium Revenue by Type (2025-2030) & (US$ Million)
Table 196. North America Enoxaparin Sodium Sales by Type (2019-2024) & (M Units)
Table 197. North America Enoxaparin Sodium Sales by Type (2025-2030) & (M Units)
Table 198. North America Enoxaparin Sodium Sales Price by Type (2019-2024) & (US$/Unit)
Table 199. North America Enoxaparin Sodium Sales Price by Type (2025-2030) & (US$/Unit)
Table 200. North America Enoxaparin Sodium Revenue by Application (2019-2024) & (US$ Million)
Table 201. North America Enoxaparin Sodium Revenue by Application (2025-2030) & (US$ Million)
Table 202. North America Enoxaparin Sodium Sales by Application (2019-2024) & (M Units)
Table 203. North America Enoxaparin Sodium Sales by Application (2025-2030) & (M Units)
Table 204. North America Enoxaparin Sodium Sales Price by Application (2019-2024) & (US$/Unit)
Table 205. North America Enoxaparin Sodium Sales Price by Application (2025-2030) & (US$/Unit)
Table 206. North America Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 207. North America Enoxaparin Sodium Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 208. North America Enoxaparin Sodium Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 209. North America Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 210. North America Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
Table 211. North America Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
Table 212. North America Enoxaparin Sodium Sales Price by Country (2019-2024) & (US$/Unit)
Table 213. North America Enoxaparin Sodium Sales Price by Country (2025-2030) & (US$/Unit)
Table 214. US Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 215. Canada Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 216. Europe Enoxaparin Sodium Revenue by Type (2019-2024) & (US$ Million)
Table 217. Europe Enoxaparin Sodium Revenue by Type (2025-2030) & (US$ Million)
Table 218. Europe Enoxaparin Sodium Sales by Type (2019-2024) & (M Units)
Table 219. Europe Enoxaparin Sodium Sales by Type (2025-2030) & (M Units)
Table 220. Europe Enoxaparin Sodium Sales Price by Type (2019-2024) & (US$/Unit)
Table 221. Europe Enoxaparin Sodium Sales Price by Type (2025-2030) & (US$/Unit)
Table 222. Europe Enoxaparin Sodium Revenue by Application (2019-2024) & (US$ Million)
Table 223. Europe Enoxaparin Sodium Revenue by Application (2025-2030) & (US$ Million)
Table 224. Europe Enoxaparin Sodium Sales by Application (2019-2024) & (M Units)
Table 225. Europe Enoxaparin Sodium Sales by Application (2025-2030) & (M Units)
Table 226. Europe Enoxaparin Sodium Sales Price by Application (2019-2024) & (US$/Unit)
Table 227. Europe Enoxaparin Sodium Sales Price by Application (2025-2030) & (US$/Unit)
Table 228. Europe Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 229. Europe Enoxaparin Sodium Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 230. Europe Enoxaparin Sodium Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 231. Europe Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 232. Europe Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
Table 233. Europe Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
Table 234. Europe Enoxaparin Sodium Sales Price by Country (2019-2024) & (US$/Unit)
Table 235. Europe Enoxaparin Sodium Sales Price by Country (2025-2030) & (US$/Unit)
Table 236. Germany Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 237. France Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 238. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 239. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 240. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 241. China Enoxaparin Sodium Revenue by Type (2019-2024) & (US$ Million)
Table 242. China Enoxaparin Sodium Revenue by Type (2025-2030) & (US$ Million)
Table 243. China Enoxaparin Sodium Sales by Type (2019-2024) & (M Units)
Table 244. China Enoxaparin Sodium Sales by Type (2025-2030) & (M Units)
Table 245. China Enoxaparin Sodium Sales Price by Type (2019-2024) & (US$/Unit)
Table 246. China Enoxaparin Sodium Sales Price by Type (2025-2030) & (US$/Unit)
Table 247. China Enoxaparin Sodium Revenue by Application (2019-2024) & (US$ Million)
Table 248. China Enoxaparin Sodium Revenue by Application (2025-2030) & (US$ Million)
Table 249. China Enoxaparin Sodium Sales by Application (2019-2024) & (M Units)
Table 250. China Enoxaparin Sodium Sales by Application (2025-2030) & (M Units)
Table 251. China Enoxaparin Sodium Sales Price by Application (2019-2024) & (US$/Unit)
Table 252. China Enoxaparin Sodium Sales Price by Application (2025-2030) & (US$/Unit)
Table 253. Asia Enoxaparin Sodium Revenue by Type (2019-2024) & (US$ Million)
Table 254. Asia Enoxaparin Sodium Revenue by Type (2025-2030) & (US$ Million)
Table 255. Asia Enoxaparin Sodium Sales by Type (2019-2024) & (M Units)
Table 256. Asia Enoxaparin Sodium Sales by Type (2025-2030) & (M Units)
Table 257. Asia Enoxaparin Sodium Sales Price by Type (2019-2024) & (US$/Unit)
Table 258. Asia Enoxaparin Sodium Sales Price by Type (2025-2030) & (US$/Unit)
Table 259. Asia Enoxaparin Sodium Revenue by Application (2019-2024) & (US$ Million)
Table 260. Asia Enoxaparin Sodium Revenue by Application (2025-2030) & (US$ Million)
Table 261. Asia Enoxaparin Sodium Sales by Application (2019-2024) & (M Units)
Table 262. Asia Enoxaparin Sodium Sales by Application (2025-2030) & (M Units)
Table 263. Asia Enoxaparin Sodium Sales Price by Application (2019-2024) & (US$/Unit)
Table 264. Asia Enoxaparin Sodium Sales Price by Application (2025-2030) & (US$/Unit)
Table 265. Asia Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 266. Asia Enoxaparin Sodium Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 267. Asia Enoxaparin Sodium Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 268. Asia Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 269. Asia Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
Table 270. Asia Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
Table 271. Asia Enoxaparin Sodium Sales Price by Country (2019-2024) & (US$/Unit)
Table 272. Asia Enoxaparin Sodium Sales Price by Country (2025-2030) & (US$/Unit)
Table 273. Japan Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 274. South Korea Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 275. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 276. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 277. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 278. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 279. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 280. Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 281. MEALA Enoxaparin Sodium Revenue by Type (2019-2024) & (US$ Million)
Table 282. MEALA Enoxaparin Sodium Revenue by Type (2025-2030) & (US$ Million)
Table 283. MEALA Enoxaparin Sodium Sales by Type (2019-2024) & (M Units)
Table 284. MEALA Enoxaparin Sodium Sales by Type (2025-2030) & (M Units)
Table 285. MEALA Enoxaparin Sodium Sales Price by Type (2019-2024) & (US$/Unit)
Table 286. MEALA Enoxaparin Sodium Sales Price by Type (2025-2030) & (US$/Unit)
Table 287. MEALA Enoxaparin Sodium Revenue by Application (2019-2024) & (US$ Million)
Table 288. MEALA Enoxaparin Sodium Revenue by Application (2025-2030) & (US$ Million)
Table 289. MEALA Enoxaparin Sodium Sales by Application (2019-2024) & (M Units)
Table 290. MEALA Enoxaparin Sodium Sales by Application (2025-2030) & (M Units)
Table 291. MEALA Enoxaparin Sodium Sales Price by Application (2019-2024) & (US$/Unit)
Table 292. MEALA Enoxaparin Sodium Sales Price by Application (2025-2030) & (US$/Unit)
Table 293. MEALA Enoxaparin Sodium Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 294. MEALA Enoxaparin Sodium Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 295. MEALA Enoxaparin Sodium Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 296. MEALA Enoxaparin Sodium Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 297. MEALA Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
Table 298. MEALA Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
Table 299. MEALA Enoxaparin Sodium Sales Price by Country (2019-2024) & (US$/Unit)
Table 300. MEALA Enoxaparin Sodium Sales Price by Country (2025-2030) & (US$/Unit)
Table 301. Mexico Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 302. Brazil Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 303. Israel Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 304. Argentina Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 305. Colombia Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 306. Turkey Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 307. Saudi Arabia Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 308. UAE Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Table 309. Key Raw Materials
Table 310. Raw Materials Key Suppliers
Table 311. Enoxaparin Sodium Distributors List
Table 312. Enoxaparin Sodium Customers List
Table 313. Research Programs/Design for This Report
Table 314. Authors List of This Report
Table 315. Secondary Sources
Table 316. Primary Sources
List of Figures
Figure 1. Enoxaparin Sodium Product Picture
Figure 2. Global Enoxaparin Sodium Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Enoxaparin Sodium Market Size Share 2019 VS 2023 VS 2030
Figure 4. 20 mg/0.2mL Picture
Figure 5. 30 mg/0.3mL Picture
Figure 6. 40 mg/0.4mL Picture
Figure 7. 60 mg/0.6mL Picture
Figure 8. 80 mg/0.8mL Picture
Figure 9. 100 mg/1mL Picture
Figure 10. 120 mg/0.8mL Picture
Figure 11. 150 mg/1mL Picture
Figure 12. 300mg/3mL Picture
Figure 13. Global Enoxaparin Sodium Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Enoxaparin Sodium Market Size Share 2019 VS 2023 VS 2030
Figure 15. Hospital Picture
Figure 16. Clinic Picture
Figure 17. Others Picture
Figure 18. Global Enoxaparin Sodium Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Enoxaparin Sodium Revenue (2019-2030) & (US$ Million)
Figure 20. Global Enoxaparin Sodium Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Enoxaparin Sodium Revenue Market Share by Region: 2023 Versus 2030
Figure 22. Global Enoxaparin Sodium Revenue Market Share by Region (2019-2030)
Figure 23. Global Enoxaparin Sodium Sales (2019-2030) & (M Units)
Figure 24. Global Enoxaparin Sodium Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Units)
Figure 25. Global Enoxaparin Sodium Sales Market Share by Region (2019-2030)
Figure 26. US & Canada Enoxaparin Sodium Sales YoY (2019-2030) & (M Units)
Figure 27. Europe Enoxaparin Sodium Sales YoY (2019-2030) & (M Units)
Figure 28. China Enoxaparin Sodium Sales YoY (2019-2030) & (M Units)
Figure 29. Asia (Excluding China) Enoxaparin Sodium Sales YoY (2019-2030) & (M Units)
Figure 30. Middle East, Africa and Latin America (Excluding China) Enoxaparin Sodium Sales YoY (2019-2030) & (M Units)
Figure 31. Global Enoxaparin Sodium Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 32. Global Enoxaparin Sodium Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 34. Global Enoxaparin Sodium Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 35. Global Enoxaparin Sodium Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 36. Global Enoxaparin Sodium Revenue Market Share by Type (2019-2030)
Figure 37. Global Enoxaparin Sodium Sales by Type (2019 VS 2023 VS 2030) & (M Units)
Figure 38. Global Enoxaparin Sodium Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 39. Global Enoxaparin Sodium Sales Market Share by Type (2019-2030)
Figure 40. Global Enoxaparin Sodium Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 41. Global Enoxaparin Sodium Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 42. Global Enoxaparin Sodium Revenue Market Share by Application (2019-2030)
Figure 43. Global Enoxaparin Sodium Sales by Application (2019 VS 2023 VS 2030) & (M Units)
Figure 44. Global Enoxaparin Sodium Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 45. Global Enoxaparin Sodium Sales Market Share by Application (2019-2030)
Figure 46. North America Enoxaparin Sodium Revenue Share by Type (2019-2030)
Figure 47. North America Enoxaparin Sodium Sales Share by Type (2019-2030)
Figure 48. North America Enoxaparin Sodium Revenue Share by Application (2019-2030)
Figure 49. North America Enoxaparin Sodium Sales Share by Application (2019-2030)
Figure 50. North America Enoxaparin Sodium Revenue Share by Country (2019-2030)
Figure 51. North America Enoxaparin Sodium Sales Share by Country (2019-2030)
Figure 52. Europe Enoxaparin Sodium Revenue Share by Type (2019-2030)
Figure 53. Europe Enoxaparin Sodium Sales Share by Type (2019-2030)
Figure 54. Europe Enoxaparin Sodium Revenue Share by Application (2019-2030)
Figure 55. Europe Enoxaparin Sodium Sales Share by Application (2019-2030)
Figure 56. Europe Enoxaparin Sodium Revenue Share by Country (2019-2030)
Figure 57. Europe Enoxaparin Sodium Sales Share by Country (2019-2030)
Figure 58. China Enoxaparin Sodium Revenue Share by Type (2019-2030)
Figure 59. China Enoxaparin Sodium Sales Share by Type (2019-2030)
Figure 60. China Enoxaparin Sodium Revenue Share by Application (2019-2030)
Figure 61. China Enoxaparin Sodium Sales Share by Application (2019-2030)
Figure 62. Asia Enoxaparin Sodium Revenue Share by Type (2019-2030)
Figure 63. Asia Enoxaparin Sodium Sales Share by Type (2019-2030)
Figure 64. Asia Enoxaparin Sodium Revenue Share by Application (2019-2030)
Figure 65. Asia Enoxaparin Sodium Sales Share by Application (2019-2030)
Figure 66. Asia Enoxaparin Sodium Revenue Share by Country (2019-2030)
Figure 67. Asia Enoxaparin Sodium Sales Share by Country (2019-2030)
Figure 68. MEALA Enoxaparin Sodium Revenue Share by Type (2019-2030)
Figure 69. MEALA Enoxaparin Sodium Sales Share by Type (2019-2030)
Figure 70. MEALA Enoxaparin Sodium Revenue Share by Application (2019-2030)
Figure 71. MEALA Enoxaparin Sodium Sales Share by Application (2019-2030)
Figure 72. MEALA Enoxaparin Sodium Revenue Share by Country (2019-2030)
Figure 73. MEALA Enoxaparin Sodium Sales Share by Country (2019-2030)
Figure 74. Enoxaparin Sodium Value Chain
Figure 75. Manufacturing Cost Structure
Figure 76. Enoxaparin Sodium Production Mode & Process
Figure 77. Direct Comparison with Distribution Share
Figure 78. Distributors Profiles
Figure 79. Years Considered
Figure 80. Research Process
Figure 81. Key Executives Interviewed
